The recent approval of ibrutinib plus obinutuzumab is a major advancement in the chronic lymphocytic leukemia space.
Suman Kambhampati, MD
Advertisement
Articles by Suman Kambhampati, MD
Advertisement
Latest Updated Articles
Expert Discusses Recent CLL ApprovalPublished: February 16th 2019 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
How Using Gender-Neutral Language Can Open Goals of Care Conversations
2
The “Owners” and “Managers” in the Peer-to-Peer Process: What an APP Should Know
3
Improving Access to Supportive Care on an Organizational Level, With Korie Bigbee
4
